Hospital Obispo Polanco
- Address
- lock Available on a paid plan
Oncology and Cardiovascular Research
At Hospital Obispo Polanco in Teruel, clinical trials are exploring care in neoplasms and cardiovascular diseases, with a strong focus on improving outcomes for people living with breast and colorectal cancer.
- ER+/HER2- early breast cancer
- Stage IV colon or rectal adenocarcinoma
- Preventing cancer recurrence and reducing venous thromboembolic risk
These studies are designed to test new treatment strategies and support better long-term disease control for patients receiving cancer care.
Digestive System Diseases
Research in digestive system diseases includes trials for diverticular disease and acute uncomplicated diverticulitis, with attention to safer and more effective outpatient management.
- Uncomplicated acute diverticulitis
- Outpatient treatment approaches with and without antibiotics
- Evaluating effectiveness and safety in routine care
These studies aim to refine everyday treatment decisions and help identify whether simpler care pathways can work well for selected patients.
Gastroenterology and Procedure Safety
The site is also studying colonoscopy-related care in patients taking antiplatelet or anticoagulant therapy, with a focus on reducing bleeding risk during polyp removal.
- Patients undergoing colonoscopy
- Postpolypectomy hemorrhage prevention
- Balancing procedure safety with ongoing blood-thinning treatment
This research supports improved diagnostic and procedural planning for people who need endoscopic evaluation while managing cardiovascular medication needs.
General Clinical Research Activity
With a small but focused portfolio, Hospital Obispo Polanco contributes to studies across oncology, gastroenterology, and cardiovascular-related care, reflecting practical research aimed at everyday patient problems.
- Testing new therapy options
- Improving safety in common procedures
- Supporting treatment effectiveness in routine hospital practice
The overall research landscape centers on applied clinical questions that can directly inform care for patients in the hospital setting.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Obispo Polanco
lock Showing 1 of 4 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acenocoumarol | 1 | Unknown | 2024-11-19 | 2024-11-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.